Release date: 2006-12-25 Clinical and cost advantages bring big demand to orthopedic materials Frost & Sullivan's research services report entitled "European Plastic Surgery Biomaterials Market" provides an overview of key market challenges and drivers, as well as market forecasts and vendors Strategic advice. The study also provides a description of the existing competitive structure and analyzes important trends affecting market performance. In this study, Frost & Sullivans' professional analysts examined the following market/application/technical areas in detail: bone substitutes, degradable scaffold materials, and orthopedic biomaterials.
What's the useful of fresh potato ? The protein in potatoes is better than soy , closest to animal protein.Potatoes are also rich in lysine and tryptophan, which cannot be compared with ordinary food.Potatoes are also high in potassium, zinc and iron.Potassium can prevent the rupture of brain blood vessels.It contains 10 times as much protein and vitamin C as apples, and contains much more vitamin B1, B2, iron and phosphorus than apples.From a nutritional standpoint, it's 3.5 times as nutritious as an apple.It's can fix with Fresh Garlic , Fresh Ginger , Air Dried Ginger, Fresh Carrot .we are not only export these products ,what you want,we can do also.what are you waiting for?Please contract with us asap.We also supplied fresh ginger ,Air Dried Ginger , Fresh garlic, White Garlic ,red garlic. Sweet Corn , Fresh Taro , Fresh Baby Mandarin, Fresh Red Grape, Fresh Pomelo , Fresh Ya Pear Chaotian Chili , Paprika Powder , Fresh Apple and so on.
Potato 60-100G,Potato 60-150G,Farm Fresh Potato,Big Fresh Potato Jining Fuyuan Fruits And Vegetables Co., Ltd. , https://www.fuyuanfv.com
In terms of technology, the study includes:
-- Biomaterials: Biomaterials are inorganic or organic, natural or synthetic materials placed in the human body for contact with biological systems to treat, enhance or replace any tissue, organ or functional group of the human body.
- Plastic Surgery Biomaterials: Plastic orthopedic biomaterials can be implanted or placed close to the fracture site to achieve recovery or compensation for missing bone tissue. Such materials for orthopedic surgery include ceramics, polymers, metals such as stainless steel, cobalt-chromium, titanium, memory alloy NiTi, and the like, as well as absorbable materials such as bioglass, hydroxyapatite and graft bone. A modification.
Regarding the market, this study points to clinical and cost advantages that bring greater demand for orthopedic biomaterials.
The significant increase in musculoskeletal diseases caused by the aging of the European population, combined with increased osteoporosis and osteoarthritis, has increased the need for the use of orthopedic biomaterials in Europe. Thus, the use of orthopedic biomaterials in craniofacial and orthopedics, including artificial bone grafts, degradable scaffold materials and bone fillers, is being discovered. The benefits of clinical and cost advantages, enhanced biocompatibility, and accelerated recovery time are expected to continue to support market development. As a result, revenue from the orthopedic biomaterials market is expected to increase from $240 million in 2005 to $609 million in 2012.
The increase in expectations for improving the quality of health care and increasing the number of medical breakthroughs has resulted in a spiral of health care costs. As a result, the government seeks a strategy to reduce costs to ensure that adequate funds are allocated to health care services. However, analysts in the study pointed out that the government's implementation of the strategy has affected the development of orthopedic biomaterials.
In order to cope with the ongoing health care reform and the current budget reduction, all parties need to reduce costs as much as possible. As market competition becomes more intense, price, service and product performance will be key factors for success. Faced with the near future, the essence of market competition will stimulate the development of innovative products and services as well as investment in capital and human resources. Therefore, analysts say that for small companies, investing in leading technologies is necessary to increase their market share. In terms of clinical applications, manufacturers will also need to closely monitor the needs of end users, position their expectations and increase their market share.
Currently, manufacturers are particularly concerned with the scope, validity, and usefulness of product invention patents and other third-party proprietary rights. Therefore, ensuring enforcement of patent and intellectual property laws will become even more important. Clearly, the success of the market will depend on the company's acquisition and approval of intellectual property rights before other competitors, which will help the preferred sellers gain critical competitiveness in the market.
—— Information from: Advanced Industrial Biotechnology Album 
